Introduction {#sec1}
============

Liverworts are nonvascular land plants usually regarded as bryophytes along with mosses and hornworts. The bryophytes are taxonomically placed between algae and pteridophytes with approximately 18 000 species or more worldwide. The liverworts contain oil bodies that are easily extracted with organic solvents, whereas the other two classes do not contain oil bodies. The *Porella* species of liverworts produces a variety of terpenoids, and a few notable classes of compounds that are isolated from these plants are the pinguisanes, chamigranes, longifolenes, and caryophylanes.^[@ref1]^ These liverworts show a broad range of interesting biological activities including anticancer,^[@ref2]^ antifeedant,^[@ref3]^ antimicrobial,^[@ref4]^ and allergenic contact dermatitis activities.^[@ref5]^ Many sesquiterpenoids that embody an unusual \[4.3.0\]nonane system with four contiguous chiral centers oriented in an all-cis fashion such as pinguisenol (**2**), naviculol (**3**), isonaviculol (**4**), acutifolone A and B (**5**, **6**), and bisacutifolone A and B (**7**, **8**) have been isolated from various liverworts by Asakawa and co-workers ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref6]^ Interesting structural features, namely two vicinal quaternary carbon atoms and four cis methyl groups on contiguous carbon atoms, in concurrence with interesting biological activities have made pinguisanes an attractive and challenging synthetic target for synthetic organic chemists ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}).

![Representative examples for pinguisane sesquiterpenes isolated from *porella* liverworts.](ao-2017-01513w_0001){#fig1}

![Synthetic approaches for acutifolone A (**5**).](ao-2017-01513w_0002){#fig2}

In this aspect, four synthetic approaches for pinguisenol (**2**)^[@ref7],[@cit8a]^ have been reported employing propargylsilane-terminated cyclization, ortho ester Claisen rearrangement, diazo ketone cyclopropanation, and α-carbonyl radical cyclization as key steps. Recently, our group has reported^[@cit8a]^ the synthesis of **2** starting from Hajos--Parrish type ketone using stereoselective cyclopropanation and diastereoselective hydrogenation using the ThalesNano H-Cube Pro flow reactor as key reactions. Similarly, acutifolone A (**5**) has been synthesized by two groups^[@ref9]^ in the racemic form; the first synthesis was reported by Nishiyama et al., following Mukayama aldol reaction as the key step; the latter was by Shia and co-workers employing Pd-mediated methylenecyclopentane annulation reaction. Although various synthetic approaches are available for pinguisanes, there is only one common approach for both pinguisenol and acutifolone A in the racemic form, following a sequence of 16 and 25 synthetic operations, respectively. As a continuation of our work on the synthesis of terpenoids,^[@ref8]^ herein, we have disclosed a concise and unified stereoselective strategy for the total synthesis of pinguisenol (**2**), isonaviculol (**4**), acutifolone A (**5**), and bisacutifolone A and B (**7**, **8**).

Results and Discussions {#sec2}
=======================

The retrosynthetic analysis for the pinguisanes is depicted in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. The synthesis of acutifolone A **5** could be derived from intermediate **12** via alkynylation and pyridinium chlorochromate (PCC)-mediated 1,3-oxidative transposition. Intermediate **12** could be synthesized following a regioselective cyclopropane ring opening reaction starting from **14** as the key transformation. Cyclopropane alcohol **14** could be accessed from enone--ester **11** via Luche reduction and a modified Simmons--Smith cyclopropanation reaction. The chiral enone ester building block **11** can be easily prepared on the gram scale from (*R*)-pulegone **16** following a known protocol.^[@ref10]^ On similar lines, isonaviculol **4** and pinguisenol **2** could be synthesized from cyclopropane compound **17** following our previous report.^[@cit8a]^ Intermediate **17** in turn could be obtained from **15** via cyclopropane alcohol intermediate **13** by employing functional groups interconversion.

![Retrosynthetic Analysis](ao-2017-01513w_0003){#sch1}

The synthesis began with the gram scale preparation of bicyclic chiral building block **15**, utilizing (*R*)-pulegone **16** as the starting material, following a known synthetic method,^[@ref10]^ that is, bromination, Favorskii rearrangement, ozonolysis, Michael addition, or intramolecular Aldol condensation. The enone carbonyl of **15** was reduced under Luche conditions^[@ref11]^ using CeCl~3~·7H~2~O and NaBH~4~ to afford allylic alcohol **18** as a single diastereomer. The diastereoselectivity in the formation of **18** can be rationalized from the preferential attack of the hydride ion from the less hindered α-face because the β-face is sterically crowded by the presence of CO~2~Me and Me groups ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). The olefinic bond of **18** was subjected to hydroxy-directed cyclopropanation using Furukawa's modified Simmons--Smith reaction conditions^[@ref12]^ to furnish cyclopropyl alcohol **13** as a single isomer. The secondary alcohol of **13** was oxidized under Dess--Martin periodinane conditions to afford keto compound **19** in good yield, which on reduction with Li--liq. NH~3~^[@ref13]^ provided the desired cyclopropane ring opened product **20** in \<10% yield ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}), along with an intractable mixture of compounds (might be due to the formation of over reduced side products related to ester and keto functionality of **19**).

![Synthesis of **15** and Further Elaboration to **20**](ao-2017-01513w_0004){#sch2}

To circumvent the steric hindrance problem associated with the cyclopropane reduction, the methyl group at the C-4 position was replaced with H in compound **15** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}). Accordingly, compound **11** was prepared in gram quantity following the known protocol starting from (*R*)-pulegone **16**.^[@ref10]^ Enone **11** was reduced under Luche conditions, which occurred stereoselectively to deliver allylic alcohol **21** as a single diastereomer.

Cyclopropanation of **21** under Furukawa's modified Simmons--Smith reaction conditions afforded compound **14** as a single isomer in good yield. The secondary hydroxyl group was converted to keto compound **22** under Dess--Martin periodinane oxidation conditions. The relative stereochemistry of the cyclopropane ring was ascertained from the single-crystal X-ray diffraction analysis[a](#fn1){ref-type="fn"} of **22** ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}). Pleasingly, treatment of cyclopropane compound **22** with lithium in liquid ammonia produced the desired quaternary methyl compound **23** in good yield ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Synthesis of Building Block **11** and Further Elaboration to **23**](ao-2017-01513w_0005){#sch3}

Compound **23** was converted to α,β-unsaturated compound **24** under Saegusa--Ito oxidation conditions^[@ref14]^ via the formation of silyl-enol ether and Pd-catalyzed dehydrosilylation reactions. To check the feasibility of 1,3-oxidative transposition reaction, we proceeded further without introducing the Me group at the C-4 position of compound **24**. Accordingly, enone **24** was treated with vinyl magnesium bromide to furnish compound **25**. Because intermediate **25** embodies two double bonds, one internal and other external ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}), the assumption was the formation of two different products **26** and **27** during the PCC-mediated 1,3-oxidative transposition reaction.^[@ref15],[@ref16]^ However, when we performed the reaction of **25** with PCC and pyridinium dichromate under various conditions, the oxidative transposition reaction occurred exclusively with the external olefin and produced the conjugated aldehyde **26** as a 2:1 mixture of *E*/*Z* isomers ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}).

![Synthesis of Enone **24** and Study of PCC-Reaction](ao-2017-01513w_0006){#sch4}

To resolve this problem, acetylide generated from trimethylsilane (TMS)-acetylene was added to enone **24**, instead of vinyl magnesium bromide, and the resultant TMS-alkyne addition compound was obtained in good yield. The TMS-protected propargyl alcohol derivative was treated with PCC, and the resultant yield of enone alkyne **28** produced was as per our expectation.^[@ref17]^ The TMS group of **28** was deprotected using K~2~CO~3~ in methanol to afford terminal alkyne **29**; further reduction of alkyne to alkene under Lindlar's hydrogenation conditions^[@ref18]^ produced the desired dieneone compound **27**, which is C-4 desmethyl-acutifolone A ([Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"}).

![Synthesis of C-4-desmethyl Acutifolone **27**](ao-2017-01513w_0007){#sch5}

To synthesize acutifolone A, it was necessary to have a preinstalled methyl group at the C-4 position. Accordingly, the methyl group in compound **24** was introduced using lithium diisopropylamide and methyl iodide (MeI) to afford compound **12** as a single diastereomer. The relative stereochemistry of the methyl center at C-4 was found to be syn with respect to the adjacent Me group at C-9 via NOESY study ([Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01513/suppl_file/ao7b01513_si_001.pdf)). Further, this substrate upon treatment with TMS-acetylide afforded the alkyne addition compound, which was subjected to PCC-mediated oxidative transposition to deliver TMS-acetylide incorporated enone **30**. The TMS protection group was removed using K~2~CO~3~ in methanol to afford terminal alkyne **31**, which on treatment with Lindlar's catalyst provided the natural product, acutifolone A, **5** in 95% yield ([Scheme [6](#sch6){ref-type="scheme"}](#sch6){ref-type="scheme"}). The spectral and analytical data, including the specific rotation of the synthesized compound, were identical with that of the reported isolation^[@cit6d]^ and synthetic values.^[@ref9]^

![Synthesis of Natural Product Acutifolone (**5**)](ao-2017-01513w_0008){#sch6}

After the successful achievement of the stereoselective synthesis of acutifolone A **5**, biomimetic Diels--Alder dimerization of **5** using previously reported conditions by Nishiyama and co-workers^[@cit9b]^ led us to deploy the same for the synthesis of bisacutifolone A **7** and B **8** using butylated hydroxytoluene (BHT) in toluene as an oxidizing agent at 125 °C in a sealed tube ([Scheme [7](#sch7){ref-type="scheme"}](#sch7){ref-type="scheme"}). As per the earlier report, Diels--Alder adduct forms first, which then undergoes double-bond migration and oxidation^[@ref19]^ to afford dimers **7** and **8** in addition to the overoxidized compound **32**. The spectral data \[^1^H and ^13^C nuclear magnetic resonance (NMR)\] and specific rotation was analogous to that of the reported values.^[@cit6d],[@cit9b]^

![Diels--Alder Dimerization of Acutifolone **5**](ao-2017-01513w_0009){#sch7}

Finally, to demonstrate the application of the synthetic strategy developed by us, synthesis of pinguisenol and isonaviculol was initiated, taking precursor **15** as the starting material ([Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}). Accordingly, the secondary hydroxy group present in **15** was protected as its *tert*-butyldiphenylsilyl (TBDPS) ether, using TBDPSCl and imidazole followed by reduction of the ester group with diisobutylaluminum hydride (DIBAL-H) to afford primary alcohol **34** in 87% yield. The primary alcohol group was protected as its tosylate using tosyl chloride and triethylamine in the presence of a catalytic amount of 4-dimethylaminopyridine (DMAP). The tosylate was then treated with LiAlH~4~ to furnish methyl derivative **17** in 55% yield over two steps ([Scheme [8](#sch8){ref-type="scheme"}](#sch8){ref-type="scheme"}).^[@ref20]^ From compound **17**, the synthesis of pinguisenol and isonaviculol was achieved following our reported transformations.^[@cit8a]^ Additionally, we also made C-6 ester analogue **35** of pinguisenol from compound **12** by following hydrogenation and vinylation reactions.

![Synthesis of Pinguisenol (**2**), Isonaviculol (**4**), and C-6 Ester Analogue of Pinguisenol](ao-2017-01513w_0010){#sch8}

Conclusions {#sec3}
===========

In summary, we have successfully achieved the first enantioselective synthesis of acutifolone A and bisacutifolone A and B in a concise manner with a good overall yield, starting from a common chiral building block derived from (*R*)-pulegone. The versatility of the developed strategy was also demonstrated by the synthesis of pinguisenol and isonaviculol. The key reactions employed in the synthesis are Luche reduction, Furukawa's modified Simmons--Smith cyclopropanation, cyclopropane ring opening with Li--liq. NH~3~, Saegusa--Ito oxidation, PCC-mediated 1,3-oxidative transposition reaction, and Diels--Alder dimerization reaction.

Experimental Section {#sec4}
====================

General Methods {#sec4-1}
---------------

Unless otherwise noted, all reagents were used as received from commercial sources. All air and moisture sensitive reactions were performed under a nitrogen or argon atmosphere in flame-dried or oven-dried glassware with magnetic stirring. Dichloromethane (CH~2~Cl~2~) was dried using CaH~2~, distilled, and stored over 4 Å molecular sieves prior to use. Tetrahydrofuran (THF) was dried over sodium metal and benzophenone and distilled prior to use. Reactions were monitored by thin-layer chromatography (TLC) (carried out on silica plates silica gel 60 F254, Merck) using ultraviolet light, iodine, and *p*-anisaldehyde for visualization. Column chromatography was carried out using silica gel (60--120 or 100--200 or 230--400 mesh) packed in glass columns. Technical grade ethyl acetate and petroleum ether were used for column chromatography and were distilled prior to use. ^1^H NMR and ^13^C NMR spectra were recorded in CDCl~3~ as the solvent on a 300 or 400 or 500 MHz spectrometer at an ambient temperature. The coupling constant *J* is given in Hz. The chemical shifts (δ) are reported in ppm scale downfield from TMS, using the residual solvent peak in CDCl~3~ (H: δ = 7.26 and C: δ = 77.0 ppm) or TMS (δ = 0.0) as the internal standard, and the signal patterns are indicated as follows: s = singlet, d = doublet, dd = doublet-of-doublet, dt = doublet-of-triplet, ddd = doublet-of-doublet-of-doublet, t = triplet, q = quartet, qd = quartet-of-doublet, m = multiplet, and br = broad. Infrared (IR) spectra were recorded on PerkinElmer spectrum 400 and Bruker infrared spectrophotometers and are reported as cm^--1^. High-resolution mass spectra (HRMS) were recorded on JEOL JMS-600 and TOF-MS spectrometers.

### (1*R*,2*R*)-Methyl-2-methyl-5-oxo-1-(3-oxopentyl)cyclopentanecarboxylate (**S-1**) {#sec4-1-1}

By following the known literature procedure^[@ref10]^ and starting from (*R*)-pulegone (3.04 g, 20 mmol), diketone--ester **S-1** was prepared as a pale yellow liquid (2.64 g, 55%). *R*~f~ = 0.3 (4:1, hexane/EtOAc); \[α\]~D~^25^ = +49.1 (*c* = 0.8, CHCl~3~); IR (neat) ν~max~: 2956, 1722, 1234, 1163, 772 cm^--1^; ^1^H NMR (300 MHz, CDCl~3~): δ 3.69 (s, 3H), 2.80 (ddd, *J* = 17.3, 10.5, 5.0 Hz, 1H), 2.57--2.37 (m, 4H), 2.30--2.01 (m, 4H), 1.92--1.66 (m, 2H), 1.04 (t, *J* = 7.4 Hz, 3H), 1.02 (d, *J* = 6.9 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 216.4, 210.8, 170.7, 61.7, 51.8, 41.9, 38.5, 37.1, 35.8, 28.1, 26.5, 15.8, 7.8; HRMS (ESIMS) calcd for C~13~H~20~O~4~Na \[M + Na\]^+^: *m*/*z*, 263.1254; found, 263.1252.

### (3*R*,3a*R*)-Methyl 3,7-Dimethyl-6-oxo-2,3,3a,4,5,6-hexahydro-1*H*-indene-3a-carboxylate (**15**) {#sec4-1-2}

By following the known literature procedure^[@ref10]^ and starting from diketo-ester **S-1** (2.5 g, 10.4 mmol), compound **15** (2.02 g, 89%) was prepared as a thick liquid. *R*~f~ = 0.4 (4:1, hexane/EtOAc); \[α\]~D~^25^ = −83.2 (*c* = 0.8, CHCl~3~); IR (neat) ν~max~: 2956, 1725, 1665, 1454, 1238, 1175 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 3.68 (s, 3H), 2.75--2.67 (m, 2H), 2.57--2.48 (m, 1H), 2.43--2.39 (m, 2H), 2.01--1.87 (m, 2H), 1.72 (t, *J* = 1.5 Hz, 3H), 1.70--1.59 (m, 2H), 0.99 (d, *J* = 6.7 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 198.5, 172.1, 164.9, 129.0, 57.2, 51.7, 46.3, 34.8, 31.7, 30.9, 30.2, 14.7, 11.3; HRMS (ESIMS) calcd for C~13~H~18~O~3~Na \[M + Na\]^+^: *m*/*z*, 245.1148; found, 245.1152.

### (3*R*,3a*R*,6*R*)-Methyl-6-hydroxy-3,7-dimethyl-2,3,3a,4,5,6-hexahydro-1*H*-indene-3a-carboxylate (**18**) {#sec4-1-3}

To a stirred solution of enone **15** (1.0 g, 4.50 mmol) in MeOH (20 mL) at −20 °C, CeCl~3~·7H~2~O (1.84 g, 4.95 mmol) was added and stirred for 5 min. Then, NaBH~4~ (188 mg, 4.95 mmol) was added and stirred for 1 h. After completion of the reaction (monitored by TLC), the reaction was quenched with saturated aq NH~4~Cl (5 mL) and water (15 mL) and extracted with EtOAc (20 mL × 3). The combined organic extract was washed with brine (20 mL), dried over Na~2~SO~4~, and evaporated to afford a crude compound, which was purified by column chromatography (4:1, hexane/EtOAc) to give pure allylic alcohol **18** as a pale yellow liquid (817 mg, 81%). *R*~f~ = 0.3 (4:1, hexane/EtOAc); \[α\]~D~^25^ = −32.1 (*c* = 0.12, CHCl~3~); IR (neat) ν~max~: 3448, 2926, 1605, 1265, 1159, 1044 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 4.05 (t, *J* = 7.9 Hz, 1H), 3.66 (s, 3H), 2.52--2.45 (m, 2H), 2.32 (dt, *J* = 17.2, 8.5 Hz, 1H), 2.20--2.15 (m, 1H), 1.87--1.81 (m, 1H), 1.70 (s, 3H), 1.69--1.62 (m, 1H), 1.55--1.46 (m, 1H), 1.43--1.35 (m, 1H), 1.15--1.09 (m, 1H), 0.92 (d, *J* = 6.9 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 174.5, 140.9, 128.7, 71.6, 56.8, 51.3, 46.0, 31.7, 31.0, 30.8, 28.3, 15.2, 15.0; HRMS (ESIMS) calcd for C~13~H~20~O~3~Na \[M + Na\]^+^: *m*/*z*, 247.1305; found, 247.1312.

### (1a*S*,2*R*,4a*R*,5*R*,7a*R*)-Methyl-2-hydroxy-1a,5-dimethyloctahydro-1*H*-cyclopropa\[*d*\]indene-4a-carboxylate (**13**) {#sec4-1-4}

To a stirring solution of diethyl zinc (4.28 mL, 1.0 M in hexane, 4.28 mmol) in CH~2~Cl~2~ (10 mL) at 0 °C, diiodomethane (0.7 mL, 8.57 mmol) was added, and the mixture was stirred at 20 °C for 30 min; meanwhile, a white solid had precipitated. To this, allylic alcohol **18** (800 mg, 3.57 mmol) in CH~2~Cl~2~ (15 mL) was added dropwise, and the solution was further stirred for 10 min at the same temperature; then, the mixture was allowed to warm to 20 °C and stirred for 24 h. The reaction mixture was quenched with aq. NH~4~Cl (15 mL) and extracted with CH~2~Cl~2~ (3 × 20 mL). The organic phase was washed with brine (20 mL), dried over Na~2~SO~4~, and concentrated under reduced pressure. The residue was purified by column chromatography on silica gel (4:1, hexane/EtOAc) to give cyclopropane alcohol **13** as a white semisolid (672 mg, 79%). *R*~f~ = 0.3 (4:1, hexane/EtOAc); \[α\]~D~^25^ = −69.4 (*c* = 0.2, CHCl~3~); IR (neat) ν~max~: 3448, 2926, 1606, 1265, 1159, 1044 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 3.78--3.73 (m, 1H), 3.69 (brs, 1H), 3.68 (s, 3H), 2.35 (ddd, *J* = 13.1, 4.7, 1.7 Hz, 1H), 2.06--2.00 (m, 1H), 1.97--1.81 (m, 2H), 1.77--1.71 (m, 2H), 1.50 (dd, *J* = 12.4, 7.9 Hz, 1H), 1.19 (s, 3H), 0.96--0.88 (m, 1H), 0.90 (d, *J* = 6.6 Hz, 3H), 0.84--0.78 (m, 1H), 0.54 (d, *J* = 5.3 Hz, 1H), 0.34 (d, *J* = 5.3 Hz, 1H); ^13^C NMR (125 MHz, CDCl~3~): δ 176.0, 67.9, 55.0, 51.0, 49.2, 36.7, 32.9, 32.7, 31.2, 29.5, 28.2, 26.4, 15.4, 15.2; HRMS (ESIMS) calcd for C~14~H~21~O~2~ \[(M -- H~2~O) + H\]^+^: *m*/*z*, 221.1542; found, 221.1530.

### (1a*S*,4a*R*,5*R*,7a*R*)-Methyl-1a,5-dimethyl-2-oxooctahydro-1*H*-cyclopropa\[*d*\]indene-4a-carboxylate (**19**) {#sec4-1-5}

To a stirred solution of secondary alcohol **13** (650 mg, 2.73 mmol) in anhydrous CH~2~Cl~2~ (20 mL) at 0 °C, Dess--Martin periodinane (1.34 g, 3.28 mmol) was added, and the reaction mixture was stirred at the same temperature for 2 h. After completion of the reaction (monitored by TLC), the reaction was quenched with a mixture of saturated aq NaHCO~3~ solution (10 mL) and saturated aq Na~2~S~2~O~3~ solution (10 mL). The reaction mixture was diluted with CH~2~Cl~2~ (20 mL), and the organic layer was separated. The aqueous layer was extracted with CH~2~Cl~2~ (2 × 30 mL), and the combined organic layer was washed with brine (50 mL) and dried over Na~2~SO~4~. The solvent was removed under reduced pressure, and the crude product was purified by silica gel column chromatography (5:1, hexane/EtOAc) to furnish 19 (574 mg, 89%) as a light yellow semisolid. *R*~f~ = 0.6 (5:1, hexane/EtOAc); \[α\]~D~^25^ = −66.4 (*c* = 0.45, CHCl~3~); IR (neat) ν~max~: 2958, 1723, 1690, 1450, 1241, 1199 cm^--1^; ^1^H NMR (300 MHz, CDCl~3~): δ 3.74 (s, 3H), 2.63 (dt, *J* = 13.5, 3.9 Hz, 1H), 2.23 (td, *J* = 15.1, 3.9 Hz, 1H), 2.13--1.94 (m, 4H), 1.84--1.80 (m, 1H), 1.61--1.55 (m, 1H), 1.41 (td, *J* = 13.8, 3.3 Hz, 1H), 1.19 (s, 3H), 1.18 (d, *J* = 4.1 Hz, 1H), 0.99 (d, *J* = 5.5 Hz, 1H), 0.93 (d, *J* = 6.3 Hz, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 210.8, 175.2, 56.8, 51.5, 48.8, 44.8, 34.7, 34.4, 33.8, 33.4, 32.4, 32.1, 15.0, 14.9; HRMS (ESIMS) calcd for C~14~H~20~O~3~Na \[M + Na\]^+^: *m*/*z*, 259.1305; found, 259.1315.

### (3*R*,3a*S*,7*S*,7a*S*)-Methyl-3,7,7a-trimethyl-6-oxo-2,3,3a,6,7,7a-hexahydro-1*H*-indene-3a-carboxylate (**20**) {#sec4-1-6}

To a stirred solution of lithium (6 mg, 0.87 mmol) in liq. NH~3~ (4.0 mL) at −33 °C, cyclopropane compound **19** (100 mg, 0.42 mmol) in THF (4 mL) was added dropwise. After 15 min, the reaction was quenched with solid NH~4~Cl (200 mg), and the reaction mixture was allowed to warm to room temperature. The reaction mixture was diluted with water and extracted with EtOAc (3 × 10 mL). The combined organic extract was washed with brine (15 mL), and the combined organic solvents were removed under reduced pressure. The crude product was directly purified by flash column chromatography (10:1, hexane/EtOAc) to afford compound **20** (9.6 mg, 9.5%) as a light yellow liquid. *R*~f~ = 0.7 (5:1, hexane/EtOAc); \[α\]~D~^20^ = +28.1 (*c* = 0.8, CHCl~3~); IR (neat) ν~max~: 1734, 1657, 1216, 758 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~): δ 3.66 (s, 1H), 2.66--2.58 (m, 1H), 2.53 (q, *J* = 6.7 Hz, 1H), 2.45--2.29 (m, 3H), 2.02--1.77 (m, 5H), 0.99 (d, *J* = 6.6 Hz, 3H), 0.98 (d, *J* = 6.9 Hz, 3H), 0.75 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 212.9, 174.7, 60.4, 53.8, 51.0, 49.5, 39.9, 37.0, 36.7, 30.3, 27.4, 18.4, 15.1, 8.6; HRMS (ESIMS) calcd for C~14~H~22~O~3~Na \[M + Na\]^+^: *m*/*z*, 261.1467; found, 261.1475.

### (1*R*,2*R*)-Methyl 2-Methyl-5-oxo-1-(3-oxobutyl)cyclopentanecarboxylate (**S-2**) {#sec4-1-7}

By following the known literature procedure^[@ref10]^ and starting from (*R*)-pulegone (7.6 g, 50 mmol), diketone ester (5.65 g, 50%) was prepared as a yellow liquid. *R*~f~ = 0.3 (4:1, hexane/EtOAc); \[α\]~D~^25^ = +53.6 (*c* = 0.6, CHCl~3~); IR (neat) ν~max~: 2959, 1747, 1726, 1237, 1167 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 3.70 (s, 3H), 2.88--2.81 (m, 1H), 2.56--2.46 (m, 2H), 2.29--2.05 (m, 4H), 2.14 (s, 3H), 1.90--1.84 (m, 1H), 1.79--1.69 (m, 1H), 1.04 (d, *J* = 6.9 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 216.2, 207.8, 170.5, 61.5, 51.6, 41.7, 38.3 (2C), 29.7, 28.0, 26.2, 15.6; HRMS (ESIMS) calcd for C~11~H~15~O~2~ \[M + H\]^+^: *m*/*z*, 249.10973; found, 249.10927.

### (3*R*,3a*R*)-Methyl 3-Methyl-6-oxo-2,3,3a,4,5,6-hexahydro-1*H*-indene-3a-carboxylate (**11**) {#sec4-1-8}

By following the known literature procedure,^[@ref10]^ from **S-2** (5.0 g, 22.1 mmol), compound **11** (3.9 g, 85%) was prepared as a thick pale yellow liquid. *R*~f~ = 0.4 (4:1, hexane/EtOAc); \[α\]~D~^25^ = −130.4 (*c* = 1.0, CHCl~3~); IR (neat) ν~max~: 2957, 1726, 1671, 1452, 1239, 1199, 1172 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 5.88 (t, *J* = 2.0 Hz, 1H), 3.72 (s, 3H), 2.92--2.86 (m, 1H), 2.77--2.73 (m, 1H), 2.60--2.52 (m, 1H), 2.41--2.37 (m, 2H), 2.02--1.90 (m, 2H), 1.71--1.62 (m, 2H), 1.03 (d, *J* = 6.6 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 198.8, 171.6, 171.4, 123.4, 57.1, 51.8, 45.9, 34.7, 31.9, 30.8, 30.4, 14.8; HRMS (ESIMS) calcd for C~12~H~17~O~3~ \[M + H\]^+^: *m*/*z*, 209.11722; found, 209.11699.

### (3*R*,3a*R*,6*R*)-Methyl 6-Hydroxy-3-methyl-2,3,3a,4,5,6-hexahydro-1*H*-indene-3a-carboxylate (**21**) {#sec4-1-9}

To a stirred solution of enone **11** (1.0 g, 4.81 mmol) in MeOH (20 mL) at −20 °C, CeCl~3~·7H~2~O (1.97 g, 5.29 mmol) was added and stirred for 5 min. Then, NaBH~4~ (201 mg, 5.29 mmol) was added and stirred for 30 min at the same temperature. After completion of the reaction (monitored by TLC), the reaction was quenched with saturated aq NH~4~Cl solution (5 mL) and water (15 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (20 mL × 3). The combined organic extract was washed with brine (20 mL), dried over Na~2~SO~4~, and evaporated to afford a crude compound, which was purified by column chromatography (4:1, hexane/EtOAc) to obtain pure allylic alcohol **21** as a semisolid compound (959 mg, 95%). *R*~f~ = 0.5 (4:1, hexane/EtOAc); \[α\]~D~^25^ = −125.3 (*c* = 0.3, CHCl~3~); IR (neat) ν~max~: 3415, 2953, 1724, 1454, 1240, 1196, 1168 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 5.51--5.49 (m, 1H), 4.30--4.24 (m, 1H), 3.68 (s, 3H), 2.74--2.66 (m, 1H), 2.56--2.52 (m, 1H), 2.33--2.26 (m, 1H), 2.17--2.11 (m, 1H), 1.89--1.82 (m, 1H), 1.74--1.66 (m, 1H), 1.52--1.43 (m, 1H), 1.36--1.28 (m, 1H), 1.17--1.12 (m, 1H), 0.94 (d, *J* = 6.9 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 174.0, 147.5, 123.6, 68.2, 56.4, 51.4, 45.9, 31.3, 31.0, 30.2, 29.5, 15.1; HRMS (ESIMS) calcd for C~12~H~18~O~3~Na \[M + Na\]^+^: *m*/*z*, 233.11482; found, 233.11456.

### (1a*S*,2*R*,4a*R*,5*R*,7a*R*)-Methyl-2-hydroxy-5-methyloctahydro-1*H*-cyclopropa\[*d*\]indene-4a-carboxylate (**14**) {#sec4-1-10}

To a stirred solution of diethyl zinc (2.86 mL, 1.0 M in hexane, 2.86 mmol) in CH~2~Cl~2~ (10 mL) at 0 °C, diiodomethane (0.46 mL, 5.72 mmol) was added, and the mixture was stirred at 20 °C for 30 min. Alcohol **21** (0.5 g, 2.38 mmol) in CH~2~Cl~2~ (10 mL) was added dropwise to the reaction mixture and stirred for 10 min at the same temperature. The mixture was allowed to warm to room temperature and stirred for 24 h. The reaction mixture was quenched with saturated aq NH~4~Cl solution (20 mL) and diluted with CH~2~Cl~2~ (20 mL). The organic layer was separated, and the aqueous layer was extracted with CH~2~Cl~2~ (3 × 20 mL). The combined organic layer was washed with brine (50 mL), dried over Na~2~SO~4~, and concentrated under reduced pressure. The residue was purified by column chromatography (4:1, hexane/EtOAc) to afford cyclopropane alcohol **14** (443 mg, 83%) as a colorless liquid. *R*~f~ = 0.4 (4:1, hexane/EtOAc); \[α\]~D~^25^ = −11.2 (*c* = 0.2, CHCl~3~); IR (neat) ν~max~: 3390, 2950, 1723, 1455, 1237, 1197, 1175, 1032 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 4.19--4.11 (m, 1H), 3.69 (s, 3H), 2.38--2.32 (m, 1H), 2.02--1.60 (m, 6H), 1.31--1.24 (s, 1H), 0.98--0.87 (m, 2H), 0.92 (d, *J* = 6.8 Hz, 3H), 0.72 (dd, *J* = 9.1, 5.3 Hz, 1H), 0.48 (t, *J* = 5.3 Hz, 1H); ^13^C NMR (75 MHz, CDCl~3~): δ 176.0, 68.1, 55.0, 51.1, 49.3, 36.7, 33.1, 32.7, 31.3, 28.3, 26.5, 15.4, 15.2; HRMS (ESIMS) calcd for C~13~H~20~O~3~Na \[M + Na\]^+^: *m*/*z*, 247.13047; found, 247.13011.

### (1a*S*,4a*R*,5*R*,7a*R*)-Methyl-5-methyl-2-oxooctahydro-1*H*-cyclopropa\[*d*\]indene-4a-carboxylate (**22**) {#sec4-1-11}

To a stirred solution of secondary alcohol **14** (0.4 g, 1.79 mmol) in anhydrous CH~2~Cl~2~ (10 mL) at 0 °C, Dess--Martin periodinane (0.9 g, 2.14 mmol) was added, and the reaction mixture was stirred at the same temperature for 2 h. After completion of the reaction (monitored by TLC), the reaction was quenched with saturated aq NaHCO~3~ solution (5 mL) and saturated aq Na~2~S~2~O~3~ solution (5 mL). The reaction mixture was diluted with CH~2~Cl~2~ (15 mL), and the layers were separated. The aqueous layer was extracted with CH~2~Cl~2~ (2 × 20 mL). The combined organic layer was washed with brine (40 mL) and dried over Na~2~SO~4~. The solvent was removed under reduced pressure, and the crude compound was purified by silica gel column chromatography (5:1, hexane/EtOAc) to afford compound **22** (361 mg, 91%), after recrystallization in hexane/EtOAc provided colorless needles. *R*~f~ = 0.4 (5:1, hexane/EtOAc); mp 82--83 °C; \[α\]~D~^25^ = −39.6 (*c* = 0.4, CHCl~3~); IR (neat) ν~max~: 2924, 1607, 1386, 1119 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~): δ 3.76 (s, 3H), 2.65 (dt, *J* = 13.6, 4.0 Hz, 1H), 2.22--2.03 (m, 3H), 2.00--1.93 (m, 2H), 1.88--1.77 (m, 2H), 1.72 (dd, *J* = 9.7, 5.1 Hz, 1H), 1.55 (td, *J* = 13.9, 3.4 Hz, 1H), 1.40 (dd, *J* = 9.7, 5.5 Hz, 1H), 1.08 (t, *J* = 5.4 Hz, 1H), 0.97 (d, *J* = 6.9 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 210.0, 175.2, 55.6, 51.6, 48.8, 40.7, 35.8, 34.6, 34.4, 33.3, 33.2, 25.4, 15.1; HRMS (ESIMS) calcd for C~13~H~19~O~3~ \[M + H\]^+^: *m*/*z*, 223.13287; found, 223.13243. X-ray: CCDC 1545177.

### (3*R*,3a*R*,7a*S*)-Methyl-3,7a-dimethyl-6-oxooctahydro-1*H*-indene-3a-carboxylate (**23**) {#sec4-1-12}

To a stirred solution of lithium (22 mg, 3.15 mmol) in liq. NH~3~ (10.0 mL) at −33 °C, cyclopropane compound 22 (350 mg, 1.58 mmol) in THF (10 mL) was added dropwise. After 15 min, the reaction was quenched with solid NH~4~Cl (500 mg), and the reaction mixture was allowed to warm to room temperature. It was diluted with water (15 mL) and extracted with diethyl ether (3 × 20 mL). The combined organic layers were washed with brine (25 mL) and removed under reduced pressure. The crude compound was directly purified by flash column chromatography (5:1, hexane/EtOAc) to obtain compound **23** (254 mg, 72%) as a white solid, after recrystallization in hexane/EtOAc provided a crystalline solid; *R*~f~ = 0.6 (5:1, hexane/EtOAc); mp 105--106 °C; \[α\]~D~^25^ = −17.1 (*c* = 0.3, CHCl~3~); IR (neat) ν~max~: 2952, 1721, 1253, 1216, 772 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 3.69 (s, 3H), 2.58--2.52 (m, 1H), 2.48 (d, *J* = 14.2 Hz, 1H), 2.42--2.25 (m, 3H), 2.09--1.99 (m, 4H), 1.80--1.72 (m, 1H), 1.50--1.44 (m, 1H), 0.99 (d, *J* = 6.9 Hz, 3H), 0.97 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 211.2, 174.5, 58.7, 52.4, 51.1, 50.0, 39.3, 39.1, 36.4, 29.9, 26.8, 23.7, 15.4; HRMS (ESIMS) calcd for C~13~H~20~O~3~Na \[M + Na\]^+^: *m*/*z*, 247.13047; found, 247.13011.

### (3*R*,3a*S*,7a*S*)-Methyl-3,7a-dimethyl-6-oxo-2,3,3a,6,7,7a-hexahydro-1*H*-indene-3a-carboxylate (**24**) {#sec4-1-13}

To a solution of **23** (224 mg, 1 mmol) in dry THF (5 mL) at −78 °C, TMSCl (0.2 mL, 1.5 mmol) was added, followed by LiHMDS (1.2 mL, 1 M sol in THF, 1.2 mmol) and stirred for 1 h. After completion of the reaction (monitored by TLC), the reaction was quenched with saturated aq NaHCO~3~ solution (5 mL) and extracted with EtOAc (3 × 20 mL). The combined organic layers were washed with brine, dried over Na~2~SO~4~, and evaporated to obtain crude silyl enolether. The resulting silylenolether (266 mg, 1 mmol) was dissolved in dimethylsulfoxide (3 mL), and Pd(OAc)~2~ (34 mg, 0.15 mmol) was added. The reaction was carried out under a positive pressure of O~2~ (balloon) at 25 °C for 12 h. After completion of the reaction, cold water (15 mL) was added and extracted with EtOAc (3 × 25 mL). The combined organic layer was dried over Na~2~SO~4~, evaporated under reduced pressure, and purified by silica gel column chromatography to afford **24** (186 mg, 84%) as a pale yellow liquid. *R*~f~ = 0.5 (5:1, hexane/EtOAc); \[α\]~D~^25^ = −45.5 (*c* = 0.2, CHCl~3~); IR (neat) ν~max~: 2927, 1726, 1660, 1241, 1206, 760 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 7.16 (d, *J* = 10.4 Hz, 1H), 5.99 (dd, *J* = 10.5, 1.0 Hz, 1H), 3.75 (s, 3H), 2.64 (d, *J* = 16.3 Hz, 1H), 2.59--2.53 (m, 1H), 2.17--2.09 (m, 3H), 1.82--1.74 (m, 1H), 1.58--1.52 (m, 1H), 1.05 (d, *J* = 7.0 Hz, 3H), 1.00 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 198.4, 172.6, 149.3, 126.6, 61.9, 51.5, 50.5, 49.4, 44.9, 38.3, 31.0, 22.6, 15.8; HRMS (ESIMS) calcd for C~13~H~18~O~3~Na \[M + Na\]^+^: *m*/*z*, 245.1148; found, 245.1152.

### (3*R*,3a*S*,7a*S*)-Methyl-3,7a-dimethyl-6-(2-oxoethylidene)-2,3,3a,6,7,7a-hexahydro-1*H*-indene-3a-carboxylate (Mixture of *E*/*Z*) (**26**) {#sec4-1-14}

To a solution of enone **24** (15 mg, 0.07 mmol) in anhydrous THF (2 mL) at 0 °C, vinylmagnesium bromide (0.14 mL of 1 M solution, 0.14 mmol) was added and stirred for 1 h. After completion of the reaction (monitored by TLC), it was quenched with saturated aq NH~4~Cl solution (1 mL) and diluted with H~2~O (1 mL) and EtOAc (5 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (2 × 5 mL). The combined organic layers were dried over Na~2~SO~4~ and evaporated under reduced pressure to give crude compound **25**. This was directly used for the next reaction.

To a stirred solution of compound **25** in anhydrous CH~2~Cl~2~ (4 mL), PCC (23 mg) and Celite (50 mg) were added at 0 °C, and the reaction mixture was allowed to stir at 25 °C for 24 h. After completion of the reaction, the reaction mixture was directly purified through silica gel flash column chromatography (5:1, hexane/EtOAc) to furnish conjugated aldehyde **26** (13.0 mg, 78%) as a mixture of *E*/*Z* isomers. *R*~f~ = 0.5, (5:1, hexane/EtOAc); IR (neat) ν~max~: 1728, 1669, 1214, 752 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~): δ 10.14 (d, *J* = 8.2 Hz, 0.5 H), 10.06 (d, *J* = 8.1 Hz, 0.9 H), 7.16 (d, *J* = 10.4 Hz, 0.4 H), 7.08 (d, *J* = 9.9 Hz, 0.5 H), 6.55--6.49 (m, 1.4 H), 6.21 (d, *J* = 9.5 Hz, 1.0 H), 5.99 (dd, *J* = 10.4, 1.0 Hz, 0.4 H), 5.90 (dd, *J* = 8.1, 1.8 Hz, 0.9 H), 5.75 (d, *J* = 8.1 Hz, 0.5 H), 3.75 (s, 2.5 Hz), 3.73 (s, 4H), 2.94 (d, *J* = 15.8 Hz, 1.0H), 2.78 (d, *J* = 15.2 Hz, 0.5H), 2.66--2.61 (m, 1.4H), 2.46--2.40 (m, 1.5H), 2.21--2.03 (m, 5.3H), 1.80--1.73 (m, 1.9H), 1.64--1.53 (m, 3.2H), 1.06--1.00 (m, 7.6H), 0.92 (s, 5.0H); ^13^C NMR (100 MHz, CDCl~3~): δ 190.6, 189.8, 173.1, 172.5, 153.9, 153.8, 149.3, 139.0, 138.9, 127.3, 127.2, 126.6, 125.6, 120.0, 62.2, 62.1, 62.0, 51.5, 51.3, 50.5, 49.4, 47.4, 47.1, 45.3, 45.1, 45.0, 44.4, 38.5, 38.3, 37.2, 31.0, 30.8, 30.7, 22.6, 22.1, 22.0, 15.8, 15.7; HRMS (ESIMS) calcd for C~15~H~21~O~3~ \[M + H\]^+^: *m*/*z*, 249.1491; found, 249.1504.

### (3*R*,3a*R*,7a*S*)-Methyl-3,7a-dimethyl-4-oxo-6-((trimethylsilyl)ethynyl)-2,3,3a,4,7,7a-hexahydro-1*H*-indene-3a-carboxylate (**28**) {#sec4-1-15}

To a stirred solution of TMS-acetylide (generated from TMS-acetylene (39 μL, 0.27 mmol) and *n*-BuLi (0.15 mL of 1.6 M solution, 0.24 mmol) in THF (2 mL) at −78 °C) enone **24** (30 mg, 0.135 mmol) in THF (1.0 mL) was added dropwise. The reaction was further stirred at −10 °C for 12 h. After completion of the reaction (monitored by TLC), it was quenched with saturated aq NH~4~Cl solution (1 mL). The reaction mixture was diluted with H~2~O (5 mL) and ethyl acetate (10 mL). The organic layer was separated, and the layer was extracted with EtOAc (2 × 10 mL). The combined organic layers were dried over Na~2~SO~4~ and removed under reduced pressure to obtain the crude compound, which was directly used for the next reaction.

The crude compound was dissolved in anhydrous CH~2~Cl~2~ (5 mL). To this were added PCC (43.5 mg, 0.20 mmol) and Celite (50 mg) at 0 °C, and the reaction mixture was allowed to stir at 25 °C for 24 h. After completion of the reaction (monitored by TLC), the solvent was evaporated, and the crude product was purified through silica gel flash column chromatography (1:10, hexane/EtOAc) to give TMS-acetylene incorporated enone **28** as a pale yellow solid (31.8 mg, 74%), after recrystallization in hexane provided a crystalline solid; mp 75--76 °C; *R*~f~ = 0.6 (1:10, hexane/EtOAc); \[α\]~D~^25^ = +41.3 (*c* = 0.2, CHCl~3~); IR (neat) ν~max~: 2959, 1726, 1668, 1208, 755 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 6.22 (d, *J* = 2.4 Hz, 1H), 3.68 (s, 3H), 2.57 (dd, *J* = 18.2, 2.4 Hz, 1H), 2.44--2.36 (m, 1H), 2.23 (d, *J* = 18.2 Hz, 1H), 2.06--1.99 (m, 1H), 1.85--1.75 (m, 1H), 1.64--1.58 (m, 1H), 1.14 (d, *J* = 6.9 Hz, 3H), 1.09 (s, 3H), 0.23 (s, 9H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.3, 170.6, 138.8, 131.0, 106.1, 103.4, 68.8, 51.2, 49.0, 41.0, 40.2, 37.8, 30.5, 23.8, −0.4 (3C); HRMS (ESIMS) calcd for C~18~H~27~O~3~Si \[M + H\]^+^: *m*/*z*, 319.1724; found, 319.1731.

### (3*R*,3a*R*,7a*S*)-Methyl-6-ethynyl-3,7a-dimethyl-4-oxo-2,3,3a,4,7,7a-hexahydro-1*H*-indene-3a-carboxylate (**29**) {#sec4-1-16}

To a stirred solution of TMS-alkyne-enone **28** (16 mg, 0.05 mmol) in MeOH (1 mL) at 0 °C, K~2~CO~3~ (7 mg, 0.05 mmol) was added, and the reaction was stirred for 1 h. After completion of the reaction (monitored by TLC), it was quenched with H~2~O (5 mL) and diluted with EtOAc (8 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over Na~2~SO~4~ and evaporated under reduced pressure. The crude product was purified by silica gel column chromatography (1:5, hexane/EtOAc) to give alkyne **29** (10.3 mg, 89%) as a colorless liquid. *R*~f~ = 0.4 (1:5, hexane/EtOAc); \[α\]~D~^25^ = +81.8 (*c* = 0.2, CHCl~3~); IR (neat) ν~max~: 2923, 2096, 1732, 1662, 1237 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 6.29 (d, *J* = 2.7 Hz, 1H), 3.69 (s, 3H), 3.52 (s, 1H), 2.58 (dd, *J* = 18.2, 2.4 Hz, 1H), 2.45--2.37 (m, 1H), 2.24 (d, *J* = 18.2 Hz, 1H), 2.07--2.00 (m, 1H), 1.86--1.76 (m, 2H), 1.65--1.59 (m, 1H), 1.15 (d, *J* = 6.9 Hz, 3H), 1.09 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.1, 170.5, 138.1, 132.0, 87.1, 82.4, 68.9, 51.2, 49.0, 40.9, 40.2, 37.8, 30.5, 23.7, 14.9; HRMS (ESIMS) calcd for C~15~H~19~O~3~ \[M + H\]^+^: *m*/*z*, 247.1334; found, 247.1326.

### (3*R*,3a*R*,7a*S*)-Methyl-3,7a-dimethyl-4-oxo-6-vinyl-2,3,3a,4,7,7a-hexahydro-1*H*-indene-3a-carboxylate (**27**) {#sec4-1-17}

To a stirred solution of alkyne **29** (10 mg) in EtOAc (1 mL), quinoline (0.1 mL of 1 M solution in EtOAc) was added. To this, Lindlar's catalyst (3 mg) was added, and the reaction mixture was stirred under a hydrogen atmosphere at 25 °C. After completion of the reaction (monitored by TLC), it was filtered through a bed of Celite and washed thoroughly with EtOAc (2 × 5 mL). The solvent was removed under reduced pressure, and the crude product was purified by column chromatography (1:5, hexane/EtOAc) to afford desmethylacutifolone **27** (9.1 mg, 91%) as a white amorphous solid; this upon recrystallization in hexane/EtOAc provided a crystalline solid; *R*~f~ = 0.5 (1:5, hexane/EtOAc); mp 96--97 °C; \[α\]~D~^20^ = +17.0 (*c* = 0.5, CHCl~3~); IR (neat) ν~max~: 2961, 1734, 1662, 1243, 1217 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~): δ 6.52 (dd, *J* = 17.6, 10.8 Hz, 1H), 5.98 (d, *J* = 2.2 Hz, 1H), 5.69 (d, *J* = 17.6 Hz, 1H), 5.48 (d, *J* = 10.8 Hz, 1H), 3.69 (s, 3H), 2.49--2.35 (m, 3H), 2.09--2.00 (m, 1H), 1.88--1.78 (m, 2H), 1.71--1.63 (m, 1H), 1.16 (d, *J* = 7.0 Hz, 3H), 1.06 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 196.7, 170.9, 152.5, 137.7, 126.1, 120.9, 69.1, 51.2, 48.7, 40.3, 38.1, 35.4, 30.6, 23.9, 15.1; HRMS (ESIMS) calcd for C~15~H~21~O~3~ \[M + H\]^+^: *m*/*z*, 249.1491; found, 249.1504.

### (3*R*,3a*S*,7*S*,7a*S*)-Methyl-3,7,7a-trimethyl-6-oxo-2,3,3a,6,7,7a-hexahydro-1*H*-indene-3a-carboxylate (**12**) {#sec4-1-18}

To a stirred solution of diisopropyl amine (0.13 mL, 0.9 mmol) in anhydrous THF (2 mL) at −78 °C, *n*-BuLi (0.5 mL of 1.6 M BuLi, 0.81 mmol) was added. The reaction mixture was warmed slowly to 0 °C and stirred for 15 min. Again, the reaction mixture was cooled to −78 °C, and enone **24** (100 mg, 0.45 mmol) in THF (1 mL) was added dropwise. After stirring the reaction mixture for 15 min at −78 °C, it was warmed to −40 °C and stirred for 30 min. Then MeI (34 μL, 0.54 mmol) in THF (0.5 mL) was added dropwise, and the resulting reaction mixture was stirred at 0 °C for 12 h. After completion of the reaction (monitored by TLC), it was quenched with a mixture of saturated aq NH~4~Cl solution (1 mL), saturated aq Na~2~S~2~O~3~ solution (1 mL), and H~2~O (3 mL) and diluted with EtOAc (5 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic layers were dried over Na~2~SO~4~ and removed under reduced pressure. The crude product was purified by silica gel column chromatography (1:5, hexane/EtOAc) to give α-methylated enone **12** (86.1 mg, 81%) as a colorless liquid. *R*~f~ = 0.5 (1:5, hexane/EtOAc); \[α\]~D~^20^ = −36.4 (*c* = 0.5, CHCl~3~); IR (neat) ν~max~: 2960, 1733, 1667, 1240, 1215 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~): δ 7.05 (d, *J* = 10.4 Hz, 1H), 5.99 (d, *J* = 10.5 Hz, 1H), 3.74 (s, 3H), 2.69--2.59 (m, 2H), 2.14--1.88 (m, 3H), 1.82--1.73 (m, 1H), 1.11 (d, *J* = 6.7 Hz, 3H), 1.05 (d, *J* = 7.0 Hz, 3H), 0.83 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 200.5, 172.8, 147.2, 126.6, 63.4, 54.9, 51.5, 47.0, 43.6, 34.8, 31.0, 17.4, 15.8, 8.4; HRMS (ESIMS) calcd for C~14~H~21~O~3~ \[M + Na\]^+^: *m*/*z*, 237.1491; found, 237.1487.

### (3*R*,3a*R*,7*S*,7a*S*)-Methyl-3,7,7a-trimethyl-4-oxo-6-((trimethylsilyl)ethynyl)-2,3,3a,4,7,7a-hexahydro-1*H*-indene-3a-carboxylate (**30**) {#sec4-1-19}

To a stirred solution of TMS-acetylide generated from TMS acetylene (60 μL, 0.42 mmol) and *n*-BuLi (0.24 mL of 1.6 M solution, 0.38 mmol) in THF (2 mL) at −78 °C, enone **12** (50 mg, 0.21 mmol) in THF (1.0 mL) was added dropwise. The reaction was stirred at −10 °C for 12 h, after it was quenched with saturated aq NH~4~Cl solution (5 mL) and diluted with diethyl ether (10 mL). The layers were separated, and the aqueous layer was extracted with diethyl ether (2 × 10 mL). The combined organic layers were dried over Na~2~SO~4~ and removed under reduced pressure. The crude compound was directly used for the next reaction.

The crude compound was dissolved in anhydrous CH~2~Cl~2~ (5 mL), PCC (68 mg, 0.32 mmol) and Celite (100 mg) were added at 0 °C, and the reaction mixture was allowed to stir at 25 °C for 24 h. After completion of the reaction (monitored by TLC), the reaction mixture was directly purified through silica gel flash column chromatography (1:10, hexane/EtOAc) to furnish TMS-acetylene incorporated enone **30** (48.5 mg, 69%) as a colorless liquid. *R*~f~ = 0.5 (1:10, hexane/EtOAc); \[α\]~D~^20^ = −17.1 (*c* = 1.0, CHCl~3~); IR (neat) ν~max~: 2927, 1735, 1662, 1236, 1214 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~): δ 6.29 (d, *J* = 2.7 Hz, 1H), 3.68 (s, 3H), 2.55 (qd, *J* = 7.2, 2.7 Hz, 1H), 2.43--2.33 (m, 1H), 2.00--1.93 (m, 1H), 1.88--1.77 (m, 2H), 1.68 (ddd, *J* = 12.6, 10.8, 5.3 Hz, 1H), 1.27 (d, *J* = 7.2 Hz, 3H), 1.14 (d, *J* = 6.8 Hz, 3H), 0.90 (s, 3H), 0.23 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~): δ 194.9, 171.0, 143.5, 131.8, 107.8, 102.9, 70.1, 53.0, 51.1, 39.8, 37.5, 35.6, 30.7, 18.3, 14.6, 14.1, −0.4; HRMS (ESIMS) calcd for C~19~H~28~O~3~NaSi \[M + Na\]^+^: *m*/*z*, 355.1705; found, 355.1701.

### (3*R*,3a*R*,7*S*,7a*S*)-Methyl-6-ethynyl-3,7,7a-trimethyl-4-oxo-2,3,3a,4,7,7a-hexahydro-1*H*-indene-3a-carboxylate (**31**) {#sec4-1-20}

To a stirred solution of TMS-alkyne-enone **30** (30 mg, 0.09 mmol) in MeOH (1 mL), K~2~CO~3~ (13 mg, 0.1 mmol) was added at 0 °C, and the reaction was stirred for 1 h. After completion of the reaction (monitored by TLC), it was quenched with H~2~O (5 mL) and diluted with EtOAc (10 mL). The layers were separated, and the aqueous layer was extracted with EtOAc (2 × 10 mL). The combined organic layers were dried over Na~2~SO~4~ and removed under reduced pressure. The crude product was purified by silica gel column chromatography (1:5, hexane/EtOAc) to produce alkyne **31** (22.5 mg, 96%) as a semisolid. *R*~f~ = 0.6 (1:5, hexane/EtOAc); \[α\]~D~^20^ = +51.2 (*c* = 0.5, CHCl~3~); IR (neat) ν~max~: 3256, 2957, 1735, 1665, 1240 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 6.35 (d, *J* = 2.6 Hz, 1H), 3.69 (s, 3H), 3.56 (s, 1H), 2.58 (qd, *J* = 7.2, 2.4 Hz, 1H), 2.43--2.35 (m, 1H), 2.05--1.95 (m, 1H), 1.88--1.79 (m, 2H), 1.72--1.65 (m, 1H), 1.29 (d, *J* = 7.2 Hz, 3H), 1.15 (d, *J* = 6.9 Hz, 3H), 0.91 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 194.7, 170.8, 142.8, 132.9, 88.4, 81.8, 70.1, 53.0, 51.2, 39.8, 37.4, 35.5, 30.6, 18.3, 14.6, 14.1; HRMS (ESIMS) calcd for C~16~H~21~O~3~ \[M + H\]^+^: *m*/*z*, 261.1491; found, 261.1483.

### (3*R*,3a*R*,7*R*,7a*S*)-Methyl 3,7,7a-Trimethyl-4-oxo-6-vinyl-2,3,3a,4,7,7a-hexahydro-1*H*-indene-3a-carboxylate (acutifolone A, **5**) {#sec4-1-21}

To a stirred solution of alkyne **31** (20 mg) in EtOAc (2 mL), quinoline (0.1 mL of 1 M solution in EtOAc) was added. Then, Lindlar's catalyst (5 mg) was added, and the reaction was stirred at 25 °C under a hydrogen atmosphere. The reaction was carefully monitored by TLC. After completion of the reaction, it was filtered through a small bed of Celite and washed thoroughly with EtOAc (5 mL). The solvent was removed under reduced pressure, and the crude compound was purified by silica gel column chromatography (1:5, hexane/EtOAc) to afford acutifolone **5** as a white solid (19.1 mg, 95%); this upon recrystallization in hexane/EtOAc provided a crystalline solid; *R*~f~ = 0.5 (1:5, hexane/EtOAc); mp 104--106 °C; \[α\]~D~^19^ = +2.17 (*c* = 0.6, CHCl~3~); lit.^[@cit6d]^ \[α\]~D~^19^ = +2.08 (*c* = 1.73, CHCl~3~); IR (neat) ν~max~: 2927, 1735, 1662, 1460, 1236, 1214, 755 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 6.45 (dd, *J* = 17.4, 10.8 Hz, 1H), 5.99 (s, 1H), 5.69 (d, *J* = 17.4 Hz, 1H), 5.45 (d, *J* = 10.8 Hz, 1H), 3.67 (s, 3H), 2.62 (q, *J* = 7.2 Hz, 1H), 2.24--2.17 (m, 1H), 1.77--1.61 (m, 3H), 1.54--1.50 (m, 1H), 1.25 (d, *J* = 7.0 Hz, 3H), 1.18 (d, *J* = 7.0 Hz, 3H), 1.11 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 197.1, 171.2, 160.3, 136.8, 124.3, 120.1, 67.4, 51.1, 49.9, 45.7, 40.9, 38.5, 31.4, 23.3, 18.0, 15.7; HRMS (ESIMS) calcd for C~16~H~23~O~3~ \[M + H\]^+^: *m*/*z*, 263.1647; found, 263.1638.

#### Diels--Alder Dimerization of Acutifolone A {#sec4-1-21-1}

A solution of **5** (15 mg, 0.057 mmol) and BHT (9.3 mg, 0.069 mmol) in toluene (0.4 mL) was heated in a sealed tube at 125 °C for 24 h. After being cooled to room temperature, the residue was purified by silica gel column chromatography (hexane/EtOAc, 10:1 to 2:1) to give **7** (3.8 mg, 25%), **8** (5.4 mg, 35%), and **32** (3.4 mg, 22%).

### (3*R*,3a*R*,5*S*,8*R*,9*S*,9a*S*)-Methyl-8-hydroxy-5-((1*R*,3a*S*,4*R*,7a*R*)-7a-(methoxycarbonyl)-1,3a,4-trimethyl-7-oxo-2,3,3a,4,7,7a-hexahydro-1*H*-inden-5-yl)-3,9,9a-trimethyl-4-oxo-2,3,3a,4, 5,6,7,8,9,9a-decahydro-1*H*-cyclopenta\[*b*\]naphthalene-3a-carboxylate (Bisacutifolone A) (**7**) {#sec4-1-22}

White solid (recrystallization in hexane/EtOAc provided a crystalline solid); mp 202--204 °C; \[α\]~D~^24^ = +61.6 (*c* = 0.13, CHCl~3~); lit.^[@cit6d]^ \[α\]~D~^24^ = +59.0 (*c* = 0.51, CHCl~3~); IR (neat) ν~max~: 2929, 1732, 1656, 1215, 1085, 1027, 800, 755 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 5.54 (d, *J* = 2.0 Hz, 1H), 4.37--4.33 (m, 1H), 3.66 (2 × s, 6H), 3.58 (t, *J* = 6.0 Hz, 1H), 2.93--2.88 (m, 1H), 2.57 (q, *J* = 6.9 Hz, 1H), 2.20--1.58 (m, 13H), 1.29 (d, *J* = 7.2 Hz, 3H), 1.27 (d, *J* = 7.0 Hz, 3H), 1.06 (d, *J* = 6.9 Hz, 3H), 1.00 (s, 3H), 0.97 (d, *J* = 6.7 Hz, 3H), 0.89 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 195.3, 195.1, 171.3, 171.2, 168.1, 159.0, 133.4, 124.1, 69.6, 69.0, 67.4, 52.5, 51.0, 50.9, 49.5, 43.7, 40.9, 40.7 (2C), 40.5, 37.0, 36.0, 31.5, 30.8, 29.5, 24.5, 23.2, 19.3, 18.2, 14.6, 13.8, 13.1; HRMS (ESIMS) calcd for C~32~H~44~O~7~Na \[M + Na\]^+^: *m*/*z*, 563.2985; found, 563.2982.

### (3*R*,3a*R*,5*S*,8*S*,9*S*,9a*S*)-Methyl 8-Hydroxy-5-((1*R*,3a*S*,4*R*,7a*R*)-7a-(methoxycarbonyl)-1,3a,4-trimethyl-7-oxo-2,3,3a,4,7,7a-hexahydro-1H-inden-5-yl)-3,9,9a-trimethyl-4-oxo-2,3,3a,4,5,6,7,8,9,9a-decahydro-1*H*-cyclopenta\[*b*\]naphthalene-3a-carboxylate (Bisacutifolone B) (**8**) {#sec4-1-23}

Pale yellow liquid. \[α\]~D~^20^ = +18.4 (*c* = 0.45, CHCl~3~); lit.^[@cit6d]^ \[α\]~D~^20^ = +18.1 (*c* = 0.74, CHCl~3~); IR (neat) ν~max~: 2952, 1733, 1656, 1215, 753 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 5.77 (d, *J* = 2.0 Hz, 1H), 4.30--4.27 (m, 1H), 3.66 (s, 3H), 3.65 (s, 3H), 3.48 (t, *J* = 5.8 Hz, 1H), 2.90 (dd, *J* = 6.9, 1.5 Hz, 1H), 2.60 (q, *J* = 7.0 Hz, 1H), 2.21--2.13 (m, 1H), 1.98--1.52 (m, 13H), 1.28 (d, *J* = 7.2 Hz, 3H), 1.15 (d, *J* = 7.0 Hz, 3H), 1.07 (d, *J* = 6.7 Hz, 3H), 1.02 (s, 3H), 1.00 (d, *J* = 6.4 Hz, 3H), 0.90 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 195.5, 195.3, 171.3, 171.2, 169.0, 159.1, 133.4, 124.4, 69.5, 66.9, 65.7, 52.5, 51.0 (2C), 48.1, 44.7, 42.2, 40.8, 40.6, 40.1, 37.1, 36.1, 31.6, 30.8, 28.8, 25.0, 24.1, 19.4, 18.2, 14.7, 13.9, 13.1; HRMS (ESIMS) calcd for C~32~H~45~O~7~ \[M + H\]^+^: *m*/*z*, 541.3165; found, 541.3163.

### (3*R*,3a*R*,5*S*,9*S*,9a*S*)-Methyl-5-((1*R*,3a*S*,4*R*,7a*R*)-7a-(methoxycarbonyl)-1,3a,4-trimethyl-7-oxo-2,3,3a,4,7,7a-hexahydro-1*H*-inden-5-yl)-3,9,9a-trimethyl-4,8-dioxo-2,3,3a,4,5,6,7,8,9,9a-decahydro-1*H*-cyclopenta\[*b*\]naphthalene-3a-carboxylate (**32**) {#sec4-1-24}

Pale yellow liquid. \[α\]~D~^20^ = +43.7 (*c* = 0.3, CHCl~3~); IR (neat) ν~max~: 2957, 1736, 1670, 1226, 758 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 5.70 (d, *J* = 2.0 Hz, 1H), 3.86 (t, *J* = 6.0 Hz, 1H), 3.66 (s, 6H), 3.00 (q, *J* = 6.9 Hz, 1H), 2.83 (dd, *J* = 7.2, 1.8 Hz, 1H), 2.68 (ddd, *J* = 16.9, 9.9, 4.6 Hz, 1H), 2.48 (ddd, *J* = 16.8, 8.1, 4.6 Hz, 1H), 2.38--2.31 (m, 1H), 2.13--2.00 (m, 2H), 1.96--1.89 (m, 1H) 1.85--1.52 (m, 8H), 1.32 (d, *J* = 7.2 Hz, 3H), 1.08 (d, *J* = 6.9 Hz, 3H), 1.06 (s, 3H), 1.03 (d, *J* = 7.0 Hz, 3H), 1.02 (d, *J* = 6.0 Hz, 3H), 0.93 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 198.9, 196.9, 194.8, 170.9, 170.6, 164.7, 150.5, 145.1, 125.4, 69.3, 66.6, 52.3, 51.2, 51.1, 48.0, 45.4, 43.1, 41.3, 40.9, 36.9, 36.5, 35.1, 35.0, 31.6, 30.8, 27.2, 24.5, 19.7, 19.3, 14.6, 13.7; HRMS (ESIMS) calcd for C~32~H~42~O~7~Na \[M + Na\]^+^: *m*/*z*, 561.2828; found, 561.2821.

### (1a*S*,2*R*,4a*R*,5*R*,7a*R*)-Methyl-2-((*tert*-butyldiphenylsilyl)oxy)-1a,5-dimethyloctahydro-1*H*-cyclopropa\[*d*\]indene-4a-carboxylate (**33**) {#sec4-1-25}

To a stirred solution of secondary alcohol **15** (175 mg, 0.74 mmol) in anhydrous CH~2~Cl~2~ (5 mL), imidazole (100 mg, 1.47 mmol) and TBDPSCl (0.3 mL, 1.11 mmol) were added at 0 °C and stirred for 24 h. After completion of the reaction (monitored by TLC), the reaction was quenched with saturated aq NaHCO~3~ (10 mL) and diluted with CH~2~Cl~2~ (10 mL). The organic layer was separated, and the aqueous layer was extracted with CH~2~Cl~2~ (3 × 15 mL). The combined organic extract was washed with brine (30 mL) and dried over Na~2~SO~4~, and the solvent was removed under reduced pressure. The crude product was purified by silica gel column chromatography (1:19, hexane/EtOAc) to afford TBDPS ether **33** (322 mg, 92%) as a pale yellow liquid. *R*~f~ = 0.8 (1:19, hexane/EtOAc); \[α\]~D~^25^ = −47.5 (*c* = 0.4, CHCl~3~); IR (neat) ν~max~: 2953, 1724, 1428, 1194, 1109, 1069, 771, 703 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~): δ 7.74--7.70 (m, 2H), 7.68--7.64 (m, 2H), 7.44--7.33 (m, 6H), 3.78 (dd, *J* = 10.6, 5.9 Hz, 1H), 3.68 (s, 3H), 2.19--2.12 (m, 1H), 1.94--1.81 (m, 2H), 1.76--1.61 (m, 2H), 1.50--1.42 (m, 2H), 1.09--1.01 (m, 1H), 1.04 (s, 9H), 0.96 (s, 3H), 0.83 (d, *J* = 6.6 Hz, 3H), 0.74 (d, *J* = 5.5 Hz, 1H), 0.59 (td, *J* = 13.6, 2.2 Hz, 1H), 0.36 (d, *J* = 5.5 Hz, 1H); ^13^C NMR (125 MHz, CDCl~3~): δ 176.2, 136.0, 134.8, 134.6, 129.4, 127.4, 127.3, 75.5, 56.2, 51.0, 49.0, 36.6, 32.9, 32.2, 30.8, 28.2, 27.9, 27.1 (3C), 23.0, 20.4, 19.5, 15.1; HRMS (ESIMS) calcd for C~30~H~40~O~3~NaSi \[M + Na\]^+^: *m*/*z*, 499.2639; found, 499.2638.

### ((1a*S*,2*R*,4a*R*,5*R*,7a*S*)-2-((*tert*-Butyldiphenylsilyl)oxy)-1a,5-dimethyloctahydro-1*H*-*cyclo*-propa\[*d*\]inden-4a-yl)methanol (**34**) {#sec4-1-26}

To a stirred solution of TBDPS-ester **33** (320 mg, 0.67 mmol) in CH~2~Cl~2~ (5 mL), DIBAL-H (1.2 mL of 20 w/v % in toluene, 1.68 mmol) was added at −10 °C, and the reaction was stirred at 0 °C for 2 h. After completion of the reaction (monitored by TLC), it was quenched with saturated sodium potassium tartrate solution (7 mL) and diluted with CH~2~Cl~2~ (10 mL), and the reaction mixture was further stirred for 1 h. The organic layer was separated, and the aqueous layer was extracted with CH~2~Cl~2~ (2 × 10 mL). The combined organic layer was dried over Na~2~SO~4~, and the solvent was removed under reduced pressure. The crude compound was purified by silica gel column chromatography (1:19, hexane/EtOAc) to give alcohol **34** as a thick oil (262 mg, 87%). *R*~f~ = 0.5 (1:19, hexane/EtOAc); \[α\]~D~^25^ = −33.9 (*c* = 0.24, CHCl~3~); IR (neat) ν~max~: 3463, 2938, 2863, 1107, 1057, 702 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 7.74--7.71 (m, 2H), 7.69--7.66 (m, 2H), 7.43--7.34 (m, 6H), 3.83 (dd, *J* = 10.2, 5.5 Hz, 1H), 3.44--3.38 (m, 2H), 1.91--1.84 (m, 1H), 1.78--1.70 (m, 1H), 1.66--1.52 (m, 2H), 1.36--1.28 (m, 2H), 1.23--1.19 (m, 1H), 1.07--1.06 (m, 1H), 1.05 (s, 9H), 1.03 (s, 3H), 1.00 (d, *J* = 6.9 Hz, 3H), 0.99 (d, *J* = 4.6 Hz, 1H), 0.63 (td, *J* = 13.6, 2.6 Hz, 1H), 0.25 (d, *J* = 4.6 Hz, 1H); ^13^C NMR (125 MHz, CDCl~3~): δ 135.9 (2C), 135.0, 134.8, 134.5, 129.6, 129.4 (2C), 127.7, 127.4, 127.3, 75.8, 64.9, 48.1, 44.4, 34.3, 33.3, 31.9, 29.9, 27.5, 27.1, 26.8, 26.6, 20.6, 19.5, 19.1, 14.6; HRMS (ESIMS) calcd for C~29~H~40~O~2~NaSi \[M + Na\]^+^: *m*/*z*, 471.2690; found, 471.2701.

### *tert*-Butyldiphenyl(((1a*S*,2*R*,4a*S*,5*R*,7a*S*)-1a,4a,5-trimethyloctahydro-1*H*-cyclopropa\[*d*\] inden-2-yl)oxy)silane (**17**) {#sec4-1-27}

To a stirred solution of primary alcohol **34** (250 mg, 0.58 mmol) in CH~2~Cl~2~ (10 mL), TsCl (220 mg, 1.16 mmol), Et~3~N (0.24 mL, 1.74 mmol), and DMAP (14.2 mg, 0.12 mmol) were sequentially added at 0 °C, and the reaction mixture was allowed to warm to 25 °C and stirred for 24 h. After completion of the reaction (monitored by TLC), it was quenched with saturated aq NH~4~Cl solution (10 mL) and diluted CH~2~Cl~2~ (10 mL). The organic layer was separated, and the aqueous layer was extracted with CH~2~Cl~2~ (3 × 15 mL); the combined organic extract was dried over Na~2~SO~4~ and removed under reduced pressure. The crude compound was used directly for the next reaction.

To a stirred solution of LiAlH~4~ (44 mg, 1.16 mmol) in THF (2 mL), tosyl compound (300 mg) in THF (2 mL) was added dropwise at room temperature. Then, the reaction mixture was warmed to 50 °C and stirred for 12 h. After completion of the reaction (monitored by TLC), it was quenched with saturated aq Na~2~SO~4~ solution (2 mL) and was further stirred for 1 h. The resulting mixture was filtered through a small bed of Celite and washed thoroughly with EtOAc (10 mL). The solvents were removed under reduced pressure, and the obtained crude compound was purified by silica gel column chromatography (100% hexane) to give Me-TBDPS compound **17** (133 mg, 55%) as a white solid; this upon recrystallization in EtOH provided colorless needles. *R*~f~ = 0.7 (100% hexane); mp 68--69 °C; \[α\]~D~^25^ = −18.3 (*c* = 0.3, CHCl~3~); ^1^H NMR (500 MHz, CDCl~3~): δ 7.75--7.72 (m, 2H), 7.71--7.68 (m, 2H), 7.44--7.34 (m, 6H), 3.80 (dd, *J* = 10.1, 5.5 Hz, 1H), 1.80--1.74 (m, 1H), 1.62--1.57 (m, 1H), 1.49--1.37 (m, 2H), 1.36--1.18 (m, 4H), 1.06 (s, 9H), 0.96 (s, 3H), 0.90 (d, *J* = 4.9 Hz, 1H), 0.84 (d, *J* = 6.6 Hz, 3H), 0.72 (dd, *J* = 13.3, 2.4 Hz, 1H), 0.68 (s, 3H), 0.03 (d, *J* = 4.9 Hz, 1H); ^13^C NMR (125 MHz, CDCl~3~): δ 136.0 (4C), 135.2, 134.8, 129.3 (2C), 127.4 (2C), 127.3 (2C), 76.3, 48.0, 39.9, 38.1, 34.9, 32.2, 31.5, 27.4, 27.4, 27.1 (3C), 20.4, 20.0, 19.5, 18.3, 14.1; IR (neat) ν~max~: 2931, 2860, 1462, 1106, 1067, 701 cm^--1^; HRMS (ESIMS) calcd for C~29~H~40~OSiNa \[M + Na\]^+^: *m*/*z*, 455.2746; found, 455.2746.

### (1*R*,3a*S*,4*S*,5*S*,7a*S*)-1,3a,4,7a-Tetramethyl-5-vinyloctahydro-1*H*-inden-5-ol (Pinguisenol) (**2**) {#sec4-1-28}

To a stirring solution of Schinzer's ketone (12 mg, 0.06 mmol) in THF (2.0 mL), vinyl magnesium bromide (0.12 mL, 0.12 mmol) was added at 0 °C and stirred for 1 h. The reaction mixture was quenched with saturated aq NH~4~Cl solution (2 mL) and diluted with EtOAc (5 mL). The organic layer was separated, and the aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic extracts were washed with brine (10 mL) and dried over Na~2~SO~4~. The organic solvents were removed under reduced pressure, and the crude compound was purified by flash column chromatography (10:1, hexane/EtOAc) to obtain pinguisenol (**2**) (12.6 mg, 92%) as a pale yellow liquid. *R*~f~ = 0.6 (10:1, hexane/EtOAc); \[α\]~D~^25^ = −21.2 (*c* = 0.6, CHCl~3~); lit.^[@cit7c]^ (antipode); \[α\]~D~^25^ = +22.5 (*c* = 2, CHCl~3~); IR (neat) ν~max~: 3403, 2930, 2866, 1515, 1462, 1378, 1219, 762 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 5.79 (dd, *J* = 17.2, 10.7 Hz, 1H), 5.17 (dd, *J* = 17.2, 0.9 Hz, 1H), 4.99 (dd, *J* = 10.7, 0.9 Hz, 1H), 2.40--2.31 (m, 1H), 1.82--1.59 (m, 5H), 1.52 (q, *J* = 7.0 Hz, 1H), 1.32--1.19 (m, 3H), 0.95 (s, 3H), 0.83 (d, *J* = 7.0 Hz, 3H), 0.81 (d, *J* = 7.2 Hz, 3H), 0.68 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 147.6, 110.6, 75.6, 47.3, 45.1, 40.3, 36.2, 34.9, 33.8, 29.1, 25.9, 19.2, 17.8, 14.6, 10.0; HRMS (ESIMS) calcd for C~15~H~25~ \[(M -- H~2~O) + H\]^+^: *m*/*z*, 205.1956; found, 205.1957.

### (*E*)-2-((1*R*,3a*S*,4*R*,7a*S*)-1,3a,4,7a-Tetramethylhexahydro-1*H*-inden-5(6*H*)-ylidene)ethanol (Isonaviculol) (**4**) {#sec4-1-29}

To a stirring solution of pinguesinol (**2**) (7.0 mg, 0.03 mmol) in anhydrous CH~2~Cl~2~ (3.0 mL), PCC (10.2 mg, 0.05 mmol) and Celite (20.0 mg) were added at 0 °C and stirred for 12 h. This mixture was filtered through a short bed of silica with the aid of CH~2~Cl~2~ (10.0 mL) and concentrated under reduced pressure to give the crude compound (7.0 mg), which was dissolved in anhydrous MeOH (2.0 mL) and cooled to −10 °C. To this were added CeCl~3~·7H~2~O (11.2 mg, 0.03 mmol) and NaBH~4~ (1.1 mg, 0.03) and stirred for 15 min. The reaction was quenched with ice water (2.0 mL), and the reaction mixture was extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with brine (2.0 mL), dried over Na~2~SO~4~, and concentrated under reduced pressure, and the crude compound was purified by silica gel flash column chromatography (10:1, hexane/EtOAc) to give isonaviculol (**4**) (4.1 mg, 58%) as a colorless liquid. *R*~f~ = 0.2 (10:1, hexane/EtOAc); \[α\]~D~^25^ = −17.1 (*c* = 0.3, CHCl~3~); lit.^[@cit6c]^ \[α\]~D~^25^ = −17.9 (*c* = 0.84, CHCl~3~); IR (neat) ν~max~: 3343, 2961, 2927, 2861, 1463, 1016, 798 cm^--1^; ^1^H NMR (500 MHz, CDCl~3~): δ 5.29 (t, *J* = 6.9 Hz, 1H), 4.22 (dd, *J* = 12.1, 8.1 Hz, 1H), 4.19 (dd, *J* = 12.4, 7.2 Hz, 1H), 2.49--2.35 (m, 2H), 2.26 (q, *J* = 6.6 Hz, 1H), 1.95 (td, *J* = 13.6, 4.9 Hz, 1H), 1.89--1.81 (m, 1H), 1.72 (ddd, *J* = 13.6, 9.6, 4.4 Hz, 1H), 1.42--1.36 (m, 1H), 1.24--1.17 (m, 1H), 1.00--0.97 (m, 1H), 0.95 (d, *J* = 6.7 Hz, 3H), 0.86 (d, *J* = 6.9 Hz, 3H), 0.66 (s, 3H), 0.62 (s, 3H); ^13^C NMR (125 MHz, CDCl~3~): δ 146.4, 119.4, 59.1, 50.2, 45.5, 40.4, 36.3, 34.6, 32.9, 29.1, 25.3, 19.0, 15.2, 15.0, 12.1; HRMS (ESIMS) calcd for C~15~H~25~ \[(M -- H~2~O) + H\]^+^: *m*/*z*, 205.1956; found, 205.1963.

### (3*R*,3a*R*,7*S*,7a*S*)-Methyl 3,7,7a-Trimethyl-6-oxooctahydro-1*H*-indene-3a-carboxylate (**20**) {#sec4-1-30}

To a stirring solution of enone--ester **12** (20 mg, 0.53 mmol) in EtOAc (1 mL) was added 10% Pd/C (10 mg); the mixture was kept under a H~2~ balloon pressure and stirred at 25 °C; and the reaction was monitored by TLC. After completion of the reaction, it was filtered through a short pad of Celite and washed with EtOAc. The filtrate was concentrated under reduced pressure, and the resulting crude compound was purified by flash column chromatography (10:1, hexane/EtOAc), which afforded olefin-reduced keto-ester **20** (19.1 mg, 95%) as a liquid. *R*~f~ = 0.7 (5:1, hexane/EtOAc).

### (3*R*,3a*R*,6*S*,7*S*,7a*S*)-Methyl 6-Hydroxy-3,7,7a-trimethyl-6-vinyloctahydro-1*H*-indene-3a-carboxylate (**35**) {#sec4-1-31}

To a stirring solution of ester ketone **20** (12 mg, 0.05 mmol) compound in THF at −10 °C vinylmagnesium bromide (0.1 mL, 0.1 mmol) was added and stirred for 15 min. The reaction mixture was quenched with sat. NH~4~Cl and diluted with water, and the reaction mixture was extracted with EtOAc (2 × 5 mL). The combined organic extract was washed with brine, and the organic layer was dried over Na~2~SO~4~. Volatiles were removed under reduced pressure, and the resulting crude compound was purified by flash column chromatography (5:1, hexane/EtOAc), which afforded an ester analogue of pinguisenol **35** (11.9 mg, 86%) as a pale yellow liquid. *R*~f~ = 0.5 (5:1, hexane/EtOAc); \[α\]~D~^20^ = −84.0 (*c* = 0.8, CHCl~3~); IR (neat) ν~max~: 3537, 2957, 1719, 1461, 1198 cm^--1^; ^1^H NMR (400 MHz, CDCl~3~): δ 5.78 (dd, *J* = 17.2, 10.8 Hz, 1H), 5.19 (dd, *J* = 17.2, 1.2 Hz, 1H), 5.03 (dd, *J* = 10.8, 1.2 Hz, 1H), 3.66 (s, 3H), 2.55--2.46 (m, 1H), 2.29 (td, *J* = 14.1, 4.0 Hz, 1H), 1.95--1.86 (m, 1H), 1.78--1.57 (m, 5H), 1.46--1.40 (m, 2H), 0.96 (s, 3H), 0.87 (d, *J* = 6.9 Hz, 3H), 0.85 (d, *J* = 6.9 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ 176.0, 147.0, 111.4, 74.6, 60.5, 50.7, 48.4, 41.5, 37.4, 35.5, 33.7, 29.8, 20.2, 18.6, 15.2, 10.1; HRMS (ESIMS) calcd for C~16~H~25~O~2~ \[(M -- H~2~O) + H\]^+^: *m*/*z*, 249.1855; found, 249.1844.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b01513](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b01513).Copies of ^1^H and ^13^C spectra for all new compounds, nOe spectra of **12**, and spectral data (^1^H and ^13^C) comparison table for natural products acutifolone A (**5**) and bisacutifolone A and B (**7** and **8**) ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01513/suppl_file/ao7b01513_si_001.pdf))X-ray crystallographic data of compound **22** ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b01513/suppl_file/ao7b01513_si_002.cif))
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